ARCHIVES

NCI Offers Informations, Resources, To Industry.

This article is from The Cancer Letter archive.

Vol. 27 No. 14 | April 6, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis.

April 30, 2004

Raub Briefs Councils On Women’s Health, Cost Containment

October 12, 1990

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996